Abstract:AbstractBackgroundThe heterogeneity of neurodegenerative diseases, including Alzheimer’s disease (AD), has hampered precision diagnosis and treatment. Machine learning methods enable the identification of genetically‐explained disease subtypes with distinct brain phenotypes.MethodGene‐SGAN is a novel, multi‐view, weakly‐supervised deep clustering method that jointly considers phenotypic and genetic data, thereby deriving subtypes of disease‐related brain changes with genetic associations. We apply the method to derive subtypes related to AD. Analyses used structural MRIs and whole‐genome sequencing data from the Alzheimer’s Disease Neuroimaging Initiative (1,533 participants, including controls and patients with Mild Cognitive Impairment (MCI) and AD).ResultGene‐SGAN identified four distinct subtypes within MCI/AD: A1, normal anatomy; A2, focal medial temporal lobe (MTL) atrophy; A3, severe atrophy in neocortex and MTL; A4, severe cortical but relatively modest MTL atrophy (Figure 1). The four subtypes reveal significant differences in seven known AD‐related genetic variants (Figure 2). The identified subtype‐associated SNPs not only resemble previous findings, but also suggest genetic protective effects contributing to the observed resilience (A1), potential inflammatory mechanisms underlying subtypes (A2&A3), and the effect of SNPs on atypical atrophy patterns of AD (A4). Clinically, A1 and A3 participants showed the best and the worst cognitive performances (Figure 3). A3 participants had the most abnormal CSF Aβ (p<0.001 vs. A1&A4 and p = 0.039 vs. A2), and exhibited the highest white matter hyperintensity (WMH) volumes (p<0.001 vs. A1&A4 and p = 0.017 vs. A2). However, A2 participants showed significantly higher CSF phospho‐tau than A3 participants (p = 0.019). A4 participants were the youngest group (p<0.001 vs. all other groups), suggesting the inclusion of early onset AD participants, who have a higher prevalence of hippocampal‐sparing variants such as posterior cortical atrophy. The four genetically‐associated subtypes also possess significant differences in a large set of plasma/CSF biomarkers, which are related to distinct biological mechanisms contributing to the heterogeneity of AD.ConclusionDeep learning revealed four morphologic/genetic MCI/AD subtypes. The derived subtypes display distinct neuroanatomical patterns and genetic determinants and also differ in many clinically interpretable biomarkers. These subtypes provide potential for drug discovery and repurposing, optimization of clinical trial recruitment, and personalized medicine based on an individual’s genetic profile.

Clustering of Alzheimer’s and Parkinson’s disease based on genetic burden of shared molecular mechanisms

Identifying Shared Diagnostic Genes and Mechanisms in Vascular Dementia and Alzheimer's Disease Via Bioinformatics and Machine Learning

Discovering Alzheimer’s Disease Subtypes with Imaging and Genetic Signatures Via Multi‐view Weakly‐supervised Deep Clustering

Genetic-based patient stratification in Alzheimer's disease

Using Multi-Scale Genetic, Neuroimaging and Clinical Data for Predicting Alzheimer’s Disease and Reconstruction of Relevant Biological Mechanisms

Machine learning identification and immune infiltration of disulfidptosis‐related Alzheimer's disease molecular subtypes

Interpretable Deep Clustering Survival Machines for Alzheimer’s Disease Subtype Discovery

Interpretable deep clustering survival machines for Alzheimer's disease subtype discovery

Elucidating Molecular Networks Underpinning Heterogeneity in Parkinson’s Disease Progression Across Clinical Manifestation Spectrum

Uncovering the Impact of Aggrephagy in the Development of Alzheimer's Disease: Insights Into Diagnostic and Therapeutic Approaches from Machine Learning Analysis

Knowledge-guided Deep Temporal Clustering for Alzheimer's Disease Subtypes in Completed Clinical Trials

Diagnosis-Guided Deep Subspace Clustering Association Study for Pathogenetic Markers Identification of Alzheimer's Disease Based on Comparative Atlases

Pathology Steered Stratification Network for Subtype Identification in Alzheimer's Disease

Probabilistic Clustering using Shared Latent Variable Model for Assessing Alzheimers Disease Biomarkers

Deciphering shared molecular dysregulation across Parkinson's disease variants using a multi-modal network-based data integration and analysis

Characterizing the clinical heterogeneity of early symptomatic Alzheimer's disease: a data-driven machine learning approach

Clinical outcome-guided deep temporal clustering for disease progression subtyping

Molecular subtyping of Alzheimer’s disease with consensus non-negative matrix factorization

Identifying the Role of Oligodendrocyte Genes in the Diagnosis of Alzheimer's Disease Through Machine Learning and Bioinformatics Analysis.

Identification of Endoplasmic Reticulum Stress-Associated Genes and Subtypes for Prediction of Alzheimer’s Disease Based on Interpretable Machine Learning

Identifying and evaluating clinical subtypes of Alzheimer’s disease in care electronic health records using unsupervised machine learning